Chris Francis
SVP, Corporate Development, Head of Emerging Areas · 2 filings · Latest: Feb 26, 2026
Wave Life Sciences Ltd.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
WVE | Chris Francis | SVP, Corporate Development, Head of Emerging Areas | Feb 26, 2026 | Sale | $15.05 | 33,194 | $499.6K | 61,867 | |
WVE | Chris Francis | SVP, Corporate Development, Head of Emerging Areas | Feb 26, 2026 | Option Exercise | $4.28 | 33,194 | $141.9K | 77,161 | |
WVE | Chris Francis | SVP, Corporate Development, Head of Emerging Areas | Feb 9, 2026 | Sale | $13.45 | 1,883 | $25.3K | 61,867 | |
WVE | Chris Francis | — | Feb 9, 2026 | Proposed Sale | $13.45 | 1,870 | $25.2K | — | |
WVE | CHRISTOPHER FRANCIS | — | Dec 8, 2025 | Proposed Sale | $7.49 | 483,602 | $3.6M | — | |
WVE | CHRISTOPHER FRANCIS | — | Nov 8, 2024 | Proposed Sale | $16.00 | 36,000 | $576.0K | — | |
WVE | CHRISTOPHER FRANCIS | — | Oct 16, 2024 | Proposed Sale | $13.67 | 208,836 | $2.9M | — |